Concepedia

Cyclophosphamide, methotrexate and infusional 5-fluorouracil (infusional CMF) in metastatic breast cancer

Kenneth J. O’Byrne, MI Koukourakis, MP Saunders, AJ Salisbury, Randi Isaacs, S.M. Varcoe, M Taylor, TS Ganesan, DC Talbot

British Journal of Cancer · 1998 · 13 citations · 25 references

DOIFull text

Open access

Concepts

References

25

Very Low Doses of Warfarin Can Prevent Thrombosis in Central Venous Catheters

Murray M. Bern · Annals of Internal Medicine · 1990 · 798 citations

, , +14

Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile.

Glen D. Heggie, Jean‐Pierre Sommadossi, David S. Cross et al. · PubMed · 1987 · 731 citations

, , +17

A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.

Ian F. Tannock, N F Boyd, George Deboer et al. · Journal of Clinical Oncology · 1988 · 348 citations

, , +17

Complications of indwelling venous access devices in cancer patients.

Brian J. Eastridge, Alan Kawarai Lefor · Journal of Clinical Oncology · 1995 · 220 citations

, , +12

High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer.

IE Smith, G. Walsh, Alison Jones et al. · Journal of Clinical Oncology · 1995 · 180 citations

, , +17